Verve Therapeutics
VERV
#6727
Rank
NZ$0.84 B
Marketcap
$9.48
Share price
3.66%
Change (1 day)
-18.24%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$5.20

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.30. In 2022 the company made an earnings per share (EPS) of -$4.88 a decrease over its 2021 EPS that were of -$4.22.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.206.66%
2022-$4.8815.54%
2021-$4.2261.32%
2020-$2.62